May 092011

Using PCR testing on BAL fluid, Denning et al (in Manchester UK) found Aspergillus DNA in 4 of 11 (36%) healthy volunteers; 21 of 22 patients with culture/microscopy-proven invasive aspergillosis; and 70-80% of patients with allergic bronchopulmonary aspergillosis or chronic pulmonary aspergillosis. Culture was positive in none of the ABPA patients, and only 17% of the CPA patients. (Other series report much higher culture positivity rates; authors suggest that yields vary widely by lab and technique, so buyer beware when relying on culture.) Most (50-75%) of the isolates from patients with ABPA and CPA had markers of triazole (itraconazole) resistance; authors suggest this may be an important previously unrecognized cause for treatment failure. Clin Infect Dis 2011;52:1123-1129.

Liked this post? Get a weekly email update, and explore our library of clinical guidelines, practice updatesreview articles. and board review questions.

PulmCCM is an independent publication not affiliated with or endorsed by any other organization, society or journal referenced on the website. (Terms of Use | Privacy Policy)

Authors: contribute your work in a guest post.


Culture may miss most PCR-confirmed, often-resistant Aspergillus